Latest filing published 22 Jun 2021 for Verve Therapeutics, Inc., €5.9M.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 8 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -74.6%Entry US$19.73 · Close at T+365 US$5.02
- -25.6%Entry US$22.06 · Close at T+365 US$16.42
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Logos Global Management LP: trading record in brief
Logos Global Management LP has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Eledon Pharmaceuticals, Inc., Dyne Therapeutics, Inc. and Verve Therapeutics, Inc. The record holds 13 filings, for trades running from 21 September 2020 to 21 June 2021.
Market trades split into 9 purchases (€19.2M) and 2 sales (€296k). Taken together, the purchases exceed the sales by €18.9M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2021: 1 purchase and no sales on the market.
In size, the median ticket on the buying side is €336k. 2 out of 9 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. After 8 purchases with a full 90-day history, the hit rate stands at 13% and the median 90-day move at -24.0%. They describe history only and say nothing certain about the share price ahead.
The record was last updated on 22 June 2021 with an open-market purchase (€5.9M) in Verve Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 7 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Logos Global Management LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- ▲
Same trade as the filing by Rock Springs Capital Management LP, counted once
7M USD31SEC370,000 shares@ US$19.00100.0% of flowCommon StockSEC:0000899243-21-025313:1Canonical exit: 19 Sept 2021 (T+90) - 443,265 sharesCommon StockSEC:0000899243-21-025313:0
- 5,000 shares@ US$24.03254.5% of flowCommon StockSEC:0001567619-20-018886:0Canonical exit: 28 Jan 2021 (T+90)
- 31,000 shares@ US$24.529928.3% of flowCommon StockSEC:0001567619-20-018886:1Canonical exit: 28 Jan 2021 (T+90)
- 4,000 shares@ US$25.9733.9% of flowCommon StockSEC:0001567619-20-018886:2Canonical exit: 28 Jan 2021 (T+90)
- 15,000 shares@ US$26.482414.8% of flowCommon StockSEC:0001567619-20-018886:3Canonical exit: 28 Jan 2021 (T+90)
- 12,942 shares@ US$26.644212.8% of flowCommon StockSEC:0001567619-20-018886:4
- 12,942 shares@ US$25.87912.5% of flowCommon StockSEC:0001567619-20-018886:5Canonical exit: 28 Jan 2021 (T+90)
- 27 shares@ US$27.020.0% of flowCommon StockSEC:0001567619-20-018886:6
- 15,000 shares@ US$26.17414.6% of flowCommon StockSEC:0001567619-20-018886:7Canonical exit: 28 Jan 2021 (T+90)
- 9,098 shares@ US$25.55078.7% of flowCommon StockSEC:0001567619-20-018886:8Canonical exit: 28 Jan 2021 (T+90)
- 700,000 shares@ US$19.00100.0% of flowCommon StockSEC:0000899243-20-026189:1Canonical exit: 20 Dec 2020 (T+90)
- 804,392 sharesCommon StockSEC:0000899243-20-026189:0
13 of 12 declarations
